Page 65 - Covid Special Issue

Website link:
https://www.icmr.gov.in/media.html
Government launched Mission COVID Suraksha to accelerate
Indian COVID-19 Vaccine Development
The Government of India announced the third stimulus package of Rs. 900 Crore for the Mission COVID Suraksha - The Indian COVID-19 Vaccine Development Mission. This grant will be provided to the Department of Biotechnology (DBT) for Research & Development of Indian COVID-19 vaccines.
The COVID-19 Vaccine development Mission with end-to-end focus from preclinical development through clinical development and manufacturing and regulatory facilitation for deployment would consolidate all available and funded resources towards an accelerated product development. This will help accelerate development of approximately 5-6 vaccine candidates and ensure that these are brought closer to licensure and introduction in market for consideration of regulatory authorities for introduction in public health systems to combat further spread of COVID-19 infection.
The important objectives of the fund will be accelerating pre-clinical and clinical development; licensure of COVID-19 vaccine candidates that are currently in clinical stages or ready to enter clinical stage of development; establishing clinical trial sites; and strengthening the existing immunoassay laboratories, central laboratories and suitable facilities for animal studies, production facilities and other testing facilities to support COVID-19 vaccine development. The other important objective will be supporting development of common harmonized protocols; trainings; data management systems; regulatory submissions; and internal and external quality management systems and accreditations. Capabilities for process development, cell line development and manufacturing of GMP batches for animal toxicology studies and clinical
61